Rapidly expanding ICU capacity for the care of critically ill patients during a surge in need in the midst of a pandemic is feasible. If appropriate resources – staff, material, space – are immediately available, such care can be provided safely and effectively. In the context of a surge in infections and increase in hospitalization and ICU admission rates arising from the SARS-CoV-2 Delta variant, these results provide support for the continued deployment of rapid Expansion-ICUs.
This work was supported by the Department of Anesthesiology and Center for Perioperative Outcomes at Weill Cornell Medicine.
This work was supported by the Department of Anesthesiology at Weill Cornell Medicine.
Availability of data and materials
There are legal and ethical restrictions on data sharing because the Institutional Review Board of Weill Cornell Medicine did not approve public data deposition. The data set used for this study constitutes sensitive patient information extracted from the electronic health record. Accordingly, it is subject to federal legislation that limits our ability to disclose it to the public. A de-identified version of the dataset underlying these findings can be requested upon reasonable request from Dr. Peter Goldstein (pag20 14@ med. corne ll. edu).
Ethics approval and consent to participate
This study was approved by the Institutional Regulatory Board of Weill Cornell Medicine. All methods were carried out in accordance with set state and federal guidelines and regulations.
Consent for publication
Consent was not obtained for this study, but information was accessed through an approved HIPAA waiver.
BMC Anesthesiol. 2022;22(209) © 2022 BioMed Central, Ltd.